What Is Cone-Rod Dystrophy? Symptoms, Causes, Diagnosis & Management Explained
Updated: 2 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer
Cone-rod dystrophy is an inherited condition that gradually destroys the retina's light-sensitive cone and rod cells, eventually causing total vision loss. Cones usually fail first, affecting central and color vision, followed by rods, affecting night and peripheral vision. Electroretinography is the main diagnostic test. There is no cure yet, but light protection and supportive therapies can slow progression. [1]
What the research says
Genetic testing finds a cause in most patients. According to PubMed, a study of 251 consecutive patients with macular and cone/cone-rod dystrophy identified disease-causing mutations in 74% of them, and one-third of the variants were novel. Mutations in ABCA4, PRPH2 and BEST1 accounted for 57% of disease cases. (Birtel et al., Sci Rep, 2018)
CRD is rare and its course is more severe than retinitis pigmentosa. A review reports a prevalence of about 1 in 40,000, notes that ABCA4 causes 30 to 60% of autosomal recessive CRDs, and describes diagnosis based on clinical history, fundus examination and electroretinogram. It concludes that no therapy currently stops the disease or restores vision, so management aims to slow degeneration, treat complications and help patients cope. (Hamel, Orphanet J Rare Dis, 2007)
Many genes are involved. A review of progressive cone and cone-rod dystrophies reports that mutations in at least 30 genes have been implicated, and that these conditions typically present with progressive loss of central vision, color vision disturbance and photophobia. (Gill et al., Br J Ophthalmol, 2019)
Key Takeaways
What it is: A retinal disease in which the eye's cone and rod photoreceptor cells gradually break down.[1]
Rarity: Rare and usually genetic; it starts early in life, in childhood or early adulthood.[1]
Progression: Gradual vision loss that eventually leads to total blindness.[1]
When cones break down: Color vision and central vision acuity decrease.[1]
When rods break down: Night vision and peripheral vision are affected.[1]
Top symptoms: Weakening central vision, light sensitivity, color trouble, night blindness and peripheral vision loss.[1]
Cause: At least 28 known genetic mutations; the four most likely are ABCA4, CRX, GUCY2D and RPGR.[1]
Inheritance: Autosomal dominant, autosomal recessive or X-linked.[1]
Main diagnostic test: Electroretinography (ERG), which measures retinal activity directly.[1]
Outlook: Not life-threatening but eventually disabling. Many people reach legal blindness by age 20, though slower forms may not reach it until the 30s or 40s.[1]
Prevention: It cannot be prevented, because it is usually genetic.[1]
What Is Cone-Rod Dystrophy?
Cone-rod dystrophy (CRD) is a type of retinal disease that causes gradual vision loss. Eventually, it causes total vision loss (blindness). The vision loss happens as the condition affects photoreceptors, the cones and rods, in your retina. CRD is rare and usually genetic. It typically starts early in life, either during childhood or early adulthood.[1]
Dystrophy of the cones and rods means they start to break down. The two cell types serve different jobs:[1]
Cones: Handle color vision and central vision acuity (clarity and sharpness). When they break down, color vision and central vision clarity decrease.
Rods: Handle night vision and peripheral (side) vision. When they break down, night vision and peripheral vision are affected.
Cones usually begin breaking down first, though sometimes cones and rods break down at about the same time.[1]
Symptoms of Cone-Rod Dystrophy
Possible CRD symptoms include the following, generally organized from early to late stage:[1]
Early: weakening central vision. Vision weakens in the center of your visual field. This usually starts during childhood.
Early: light sensitivity (photophobia). Pronounced, uncomfortable sensitivity to light.
Early to mid: color trouble. Trouble distinguishing colors and, eventually, color blindness.
Mid: night blindness (nyctalopia). Difficulty seeing in low light or at night.
Late: peripheral vision loss. The outer edges of your visual field fade.
Most advanced: total vision loss. Blindness is the most advanced stage.
The early symptoms often overlap, so a child who squints in sunlight, struggles with reading, or seems clumsy in dim light may be showing the first signs of cone breakdown.
What Causes Cone-Rod Dystrophy?
CRD is usually genetic, meaning it happens because of DNA changes (genetic mutations). So far, research shows at least 28 separate mutations can cause it.[1] Counts differ by source: a 2019 review reports that mutations in at least 30 genes have been implicated.[4]
The four gene mutations that are most likely to cause cone-rod dystrophy include:[1]
ABCA4: Among the most common CRD-related mutations.
CRX: A common CRD-related mutation.
GUCY2D: A common CRD-related mutation.
RPGR: A common CRD-related mutation.
How Is Cone-Rod Dystrophy Diagnosed?
An eye care specialist can diagnose cone-rod dystrophy using a combination of methods and tools. That includes getting a detailed history, asking about your medical history and any vision loss or changes you've experienced. They'll also perform an eye exam, which can include:[1]
Visual acuity test: How clearly you can see at a distance (sharpness of vision).
Color vision test: How well you can distinguish colors.
Slit lamp exam: A close inspection of the eye's structures under magnified light.
While those methods are helpful, the main test to diagnose cone-rod dystrophy is a special ophthalmic electrophysiology test called electroretinography. This test measures retinal activity directly and can detect specific activity patterns (or lack thereof) that can confirm or rule out CRD.[1]
When is genetic testing recommended?
Your eye care specialist or a healthcare provider may also recommend genetic testing to see if you have a mutation known to cause cone-rod dystrophy. Your provider will likely recommend this testing if a close family member (a biological parent, sibling or child) develops CRD, or if there's a chance you might pass CRD to your biological children.[1]
How Is Cone-Rod Dystrophy Treated?
Unfortunately, there isn't a treatment for CRD. For now, the only approach is to slow its progression (how fast it gets worse). Your eye care specialist can treat some of the symptoms or complications. That often includes:[1]
Light protection: Light-blocking accessories such as sunglasses, tinted eyeglasses or tinted contact lenses can slow the breakdown of retinal cells from light exposure.
Vision correction: Prescription lenses help compensate for decreasing vision early on.
Low vision aids: Tools, devices and technology, from low-tech magnifying glasses to high-tech screen-reading computer programs, help you work around the vision loss. See our guide to living with low vision.
Visual rehabilitation: Rehab therapy helps you learn ways to compensate for or work around vision loss.
Nutritional supplements: Some micronutrients (vitamins or minerals) may help slow CRD progression. Your specialist can guide you on which supplements to use or avoid.
Mental health support: Losing vision can be stressful and scary. Many people with CRD experience symptoms of anxiety or depression related to their vision changes. Mental healthcare helps you process emotions and develop coping strategies.
Research and future treatment options
Researchers are currently investigating whether gene therapies can treat cone-rod dystrophy. Those treatments are still in the very early testing phases of the research process, meaning it will be several years (at minimum) before they become available, and that hinges on the research showing they're safe and effective. While those treatments aren't an option right now, they may offer hope in the future to those with CRD.[1]
Outlook, Prevention and Living With Cone-Rod Dystrophy
What can you expect if you have CRD?
The effects of cone-rod dystrophy start during childhood. Children with CRD usually have vision issues before age 10, so teachers or other education professionals may be the first to notice the effects.[1]
Many people with cone-rod dystrophy often have vision loss severe enough to meet the criteria for legal blindness by age 20. But sometimes the damage is slower and/or less severe, delaying vision loss. People with slower-progressing CRD may not meet the legal blindness criteria until their 30s or 40s.[1]
What's the outlook?
CRD isn't life-threatening, but it is a disruptive and eventually disabling condition. You can learn to live with vision loss, especially with assistance from medical professionals, support programs and other resources.[1]
Can cone-rod dystrophy be prevented?
Cone-rod dystrophy usually happens because of genetic mutations, so there's no way, at least for now, to prevent CRD or reduce your risk of developing it. Researchers are still looking for other causes or contributing factors.[1]
How do you take care of yourself with CRD?
If you have CRD, it's important to see an eye care specialist regularly so they can monitor your eyes for changes and help adjust treatments accordingly. They can also keep you informed about treatment option changes or other things you need to know. Your eye care specialist and other healthcare providers can greatly help you during the progression of CRD, helping you learn how to work around it and preparing you for what's to come. Part of their job involves staying up to date with research advances so they can keep you informed about new treatments that might help.[1]
What questions should you ask your doctor?
How advanced is my vision loss?
How will the CRD progress, and what is the most likely timeline?
Should I and/or other family members undergo genetic testing to determine the DNA mutation(s) behind the CRD?
What can I do now to delay the progression?
Are there programs or resources that can help me adapt to current changes or prepare for future ones?
Conclusion
Cone-rod dystrophy is a rare, inherited retinal disease that takes its name from the two kinds of light-sensing cells it destroys. The cones, responsible for sharp central vision and color perception, typically break down first, which is why the earliest signs often appear in childhood as blurring in the center of vision, pronounced light sensitivity and trouble distinguishing colors. The rods, responsible for seeing in dim light and at the edges of your field of vision, follow, bringing night blindness and peripheral vision loss before the condition reaches its most advanced stage: total blindness.
The genetic picture is well established. At least 28 separate DNA mutations can cause CRD, passed on through autosomal dominant, autosomal recessive or X-linked inheritance, with ABCA4, CRX, GUCY2D and RPGR the four most likely culprits. Diagnosis depends on electroretinography, a specialized test that measures retinal activity directly, backed up by a detailed history, an eye exam with visual acuity, color vision and slit lamp testing, and, when appropriate, genetic testing for affected families.
There is no cure today, but the condition is manageable. Light-blocking sunglasses and tinted lenses slow the light-driven breakdown of retinal cells; prescription lenses, magnifiers and screen-reading software help people work around their declining vision; visual rehabilitation teaches new ways to navigate the world; and targeted mental health support addresses the anxiety and depression that often accompany progressive vision loss. Gene therapy research is still in its earliest phases, but it carries genuine promise for the future.
CRD is not life-threatening, but it is disruptive, and living with it is a marathon, not a sprint. Regular specialist care, family screening and adaptive resources make a meaningful difference. If you or your child are noticing early signs, such as squinting in bright light, difficulty reading or clumsiness in dim rooms, an appointment with an eye care specialist is the best first step.
If clear visual explanations of eye conditions would help you or your family understand diagnosis results and care options, explore Rinnit's infographic templates, designed to turn complex medical information into clear, shareable visuals.
Frequently Asked Questions
What is cone-rod dystrophy?
Cone-rod dystrophy (CRD) is a type of retinal disease that causes gradual vision loss by breaking down the photoreceptors (cones and rods) in your retina. It eventually causes total vision loss (blindness).[1]
Is cone-rod dystrophy rare?
What age does cone-rod dystrophy start?
It typically starts early in life, during childhood or early adulthood. Children with CRD usually have vision issues before age 10.[1]
What are photoreceptors?
Photoreceptors are the light-sensing cells of the retina: cones (for color and central vision) and rods (for night and peripheral vision).[1]
What do cones do in the eye?
Cones handle color vision and central vision acuity (clarity and sharpness).[1]
What do rods do in the eye?
Rods handle night vision and peripheral (side) vision.[1]
Which cells break down first in CRD?
Cones usually begin breaking down first, though sometimes cones and rods break down at about the same time.[1]
What happens as cones break down?
As cones break down, color vision and central vision acuity decrease.[1]
What happens as rods break down?
When rods break down, night vision and peripheral vision are affected.[1]
What are the symptoms of cone-rod dystrophy?
Weakening central vision, pronounced light sensitivity (photophobia), trouble distinguishing colors that can lead to color blindness, night blindness (nyctalopia), peripheral vision loss, and eventually total vision loss.[1]
Does cone-rod dystrophy start with central vision loss?
Weakening vision in the center of your visual field is an early symptom that usually starts during childhood.[1]
What is photophobia in CRD?
Pronounced sensitivity to light, a common early symptom of cone-rod dystrophy.[1]
Does CRD cause color blindness?
It causes trouble distinguishing colors and, eventually, color blindness.[1]
What is nyctalopia?
Nyctalopia is night blindness, difficulty seeing in low light. It is one of the rod-related symptoms of CRD.[1]
Does CRD cause peripheral vision loss?
Yes. Peripheral (side) vision loss occurs as the rods break down.[1]
Can cone-rod dystrophy cause total blindness?
Total vision loss (blindness) is the most advanced stage of CRD.[1]
What causes cone-rod dystrophy?
CRD is usually genetic. It happens because of DNA changes (genetic mutations). At least 28 separate mutations are known to cause it, and a 2019 review reports mutations in at least 30 genes.[1][4]
What are the most common CRD genes?
The four most likely to cause cone-rod dystrophy are ABCA4, CRX, GUCY2D and RPGR.[1]
What is autosomal dominant inheritance?
A pattern where you can inherit the condition if only one biological parent passes the mutation to you.[1]
What is autosomal recessive inheritance?
A pattern where you can only inherit the condition if both biological parents pass the mutation to you.[1]
What is X-linked inheritance?
A pattern where the risk varies depending on which biological parent has the mutation.[1]
Is cone-rod dystrophy inherited?
It is usually genetic, passed on through autosomal dominant, autosomal recessive or X-linked patterns.[1]
Can a person with no known family history still have CRD?
CRD is genetic, but researchers are still looking for other causes or contributing factors. Genetic testing can help clarify whether a known mutation is involved.[1]
Who diagnoses cone-rod dystrophy?
An eye care specialist can diagnose cone-rod dystrophy using a combination of methods and tools.[1]
What is included in the diagnostic eye exam?
A detailed medical and vision history plus an eye exam that can include a visual acuity test, a color vision test and a slit lamp exam.[1]
What is electroretinography?
A special ophthalmic electrophysiology test that measures retinal activity directly. It is the main test for diagnosing cone-rod dystrophy because it can detect activity patterns (or a lack of them) that confirm or rule out CRD.[1]
When is genetic testing recommended for CRD?
Genetic testing may be recommended if a close family member (biological parent, sibling or child) develops CRD, or if there's a chance you might pass CRD to your biological children.[1]
Can genetic testing find the cause of CRD?
Often. In a study of 251 patients with macular and cone/cone-rod dystrophy, disease-causing mutations were identified in 74%.[2]
Is there a cure for cone-rod dystrophy?
No. There isn't a treatment for CRD yet. The only approach for now is to slow its progression.[1]
Can treatment slow CRD progression?
The current approach focuses on slowing how fast it gets worse, mainly through light protection and supportive therapies.[1]
How do sunglasses help with CRD?
Light-blocking accessories like sunglasses, tinted eyeglasses or tinted contact lenses can slow the breakdown of retinal cells caused by light exposure.[1]
Can prescription lenses help with CRD?
Prescription lenses can help compensate for decreasing vision early on.[1]
What are low vision aids?
Tools, devices and technology that help you work around vision loss, from low-tech magnifying glasses to high-tech screen-reading computer programs.[1]
What is visual rehabilitation?
Rehab therapy that helps you learn ways to compensate for or work around vision loss.[1]
Can supplements help cone-rod dystrophy?
Some micronutrients (vitamins or minerals) may help slow CRD progression. Your eye care specialist can guide you on which supplements to use or avoid.[1]
Does CRD affect mental health?
Losing vision can be stressful and scary. Many people with CRD experience symptoms of anxiety or depression related to their vision changes, and mental healthcare can help them process emotions and develop coping strategies.[1]
What is gene therapy for cone-rod dystrophy?
Researchers are investigating whether gene therapies can treat CRD. The treatments are still in very early testing phases, so availability is at least several years away and depends on proving safety and effectiveness.[1]
Will gene therapy be available soon?
Not yet. It will take several years (at minimum), and only if research shows the treatments are safe and effective.[1]
What is the outlook for people with CRD?
CRD isn't life-threatening, but it is disruptive and eventually disabling. Many people learn to live with vision loss through medical professionals, support programs and other resources.[1]
Do most people with CRD become legally blind?
Many people with CRD have vision loss severe enough to meet the criteria for legal blindness by age 20.[1]
Can CRD progress more slowly in some people?
Yes. Sometimes the damage is slower and/or less severe, and people with slower-progressing CRD may not meet legal blindness criteria until their 30s or 40s.[1]
Can cone-rod dystrophy be prevented?
No. Because it usually results from genetic mutations, there's no way, at least for now, to prevent CRD or reduce your risk.[1]
How often should someone with CRD see an eye care specialist?
Regularly, so they can monitor your eyes for changes, adjust treatments and keep you informed about advances and resources.[1]
What questions should I ask my doctor about CRD?
Ask how advanced your vision loss is, how CRD will progress and on what timeline, whether you or family members should have genetic testing, what you can do now to delay progression, and what programs or resources can help you adapt.[1]
Who might notice CRD symptoms in a child first?
Teachers or other education professionals may be the first to notice, since vision issues typically appear before age 10.[1]
Is it normal to feel anxious or scared with CRD?
Yes. Vision loss can make you feel cut off or isolated from others, and anxiety or fear about the future is understandable. Eye care specialists and other providers can offer care, support, guidance and resources.[1]
Can people with CRD live well with the condition?
You can learn to live with vision loss, especially with assistance from medical professionals, support programs and adaptive resources.[1]
Is cone-rod dystrophy life-threatening?
No. CRD isn't life-threatening, though it is disruptive and eventually disabling.[1]
Related Reading
Blindness: The Complete Loss of Vision That Affects About 1 Million Americans — and What Medicine Can and Cannot Fix — understanding total vision loss.
Color Blindness (Color Vision Deficiency): Symptoms, Causes, Diagnosis & Living Tips — Complete Guide — causes and types of color vision problems.
Genetic Mutations: Understanding the Blueprint of Human Variation — how DNA changes happen.
Living with Low Vision: A Guide to Management and Rehabilitation — practical tools and rehabilitation for low vision.
Anxiety Disorders: Symptoms, Types, Causes, Treatment & Complete Guide — support when vision loss brings worry.
What Is Clinical Depression (Major Depressive Disorder)? Symptoms, Causes, Diagnosis and Treatment — signs of depression and when to seek help.
References
Cleveland Clinic. Cone-Rod Dystrophy. Cleveland Clinic. Medically reviewed; last updated October 4, 2024. https://my.clevelandclinic.org/health/diseases/cone-rod-dystrophy
Birtel J, Eisenberger T, Gliem M, et al. Clinical and genetic characteristics of 251 consecutive patients with macular and cone/cone-rod dystrophy. Sci Rep. 2018;8(1):4824. PMID 29555955. https://doi.org/10.1038/s41598-018-22096-0
Hamel CP. Cone rod dystrophies. Orphanet J Rare Dis. 2007;2:7. PMID 17270046. https://doi.org/10.1186/1750-1172-2-7
Gill JS, Georgiou M, Kalitzeos A, et al. Progressive cone and cone-rod dystrophies: clinical features, molecular genetics and prospects for therapy. Br J Ophthalmol. 2019;103(5):711-720. PMID 30679166. https://doi.org/10.1136/bjophthalmol-2018-313278
Medical disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition or before starting or changing any treatment plan. Progressive vision loss warrants regular evaluation by an eye care specialist.
Comments